The Prescription Medicines Code of Practice Authority
To return to the home page click on the PMCPA logo.
Please note, to continue to receive eAlerts from the PMCPA you must resubmit your details in the box above.
Below is an introduction to the new PMCPA website.
Welcome
The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI. It was established by the ABPI on 1 January 1993.
The Authority is responsible for the provision of advice, guidance and training on the Code as well as for the complaints procedure. It is also responsible for arranging for conciliation between companies when requested to do so and for arranging for the scrutiny of advertising and meetings on a regular basis.
The PMCPA was established by The Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry, independently of the ABPI.
The aim of the Code is to ensure that the promotion of medicines by the pharmaceutical industry is carried out within a robust framework, to support high quality patient care.
Code of Practice Seminars
The PMCPA holds regular training seminars on the requirements of the Code of Practice. They are designed to explain the requirements of the Code, and are open to all.
Our free online eLearning tool is currently being updated.
The link follows for more information about Training opportunities.
Media
-
Daiichi-Sankyo, GW Pharmaceuticals, Bayer plc, Proveca Ltd, Otsuka UK and Otsuka Europe have been named in advertisements following breaches.
27 July 2019
read more -
The MHRA has issued guidance regarding the process for the conversion of centrally approved products (CAPs) to UK marketing authorizations in relation to preparation in the event of the UK leaving the EU with no deal.
10 April 2019
read more
